Olaparib Tablets 150 Mg – Generic Lynparza
$255.00 – $690.00Price range: $255.00 through $690.00
Olaparib Tablets 150 Mg
are oral, prescription-only medications used to treat advanced cancers associated with BRCA mutations. It is a PARP inhibitor indicated for ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. Trusted by oncologists globally for its targeted cancer therapy with fewer side effects than traditional chemotherapy.
Description
Olaparib Tablets 150 Mg – Generic Lynparza
Olaparib Tablets 150 Mg – Generic Lynparza is a targeted anticancer medicine used to treat certain cancers such as ovarian, breast, pancreatic, and prostate cancers associated with BRCA gene mutations. It belongs to a class of drugs called PARP inhibitors, which block cancer cells from repairing DNA, leading to their destruction and slowing disease progression.
Mechanism of Action
PARP Enzyme Inhibition
Olaparib blocks the PARP enzyme, which cancer cells use to repair damaged DNA.
Cancer Cell Death
This results in accumulation of DNA damage, causing selective death of cancer cells while sparing normal cells.
Medical Uses
Olaparib Tablets 150 Mg is used for:
- Ovarian cancer (BRCA-mutated)
- Breast cancer (HER2-negative with BRCA mutation)
- Pancreatic cancer
- Prostate cancer
Dosage and Administration
It is taken orally as prescribed by an oncologist, usually twice daily. The dosage depends on patient condition and treatment plan. It can be taken with or without food. Regular monitoring, including blood tests, is required to ensure safety and effectiveness during therapy.
Clinical Effectiveness
Clinical studies have shown that Olaparib significantly improves progression-free survival by targeting tumor DNA repair mechanisms, especially in patients with BRCA mutations.
Safety and Side Effects
Common Side Effects
- Nausea
- Fatigue
- Anemia
- Vomiting
Serious Risks
- Bone marrow suppression
- Lung inflammation (rare)
- Secondary malignancies (rare)
Regular medical monitoring is essential during treatment.
Contraindications and Precautions
Olaparib should be used with caution in:
- Patients with low blood counts
- Pregnant or breastfeeding women
- Patients with kidney or lung disease
Strict medical supervision is required.
Drug Interactions
Olaparib may interact with certain antifungals, antibiotics, and other anticancer medications. Patients should inform their healthcare provider about all medicines they are taking to avoid complications and ensure safe treatment.
FAQs
Olaparib 150 Mg is used to treat cancers such as ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations. It helps slow disease progression and improve survival. It is often used as maintenance therapy or after other treatments in patients with specific genetic conditions.
Olaparib works by inhibiting the PARP enzyme responsible for repairing DNA damage in cancer cells. This leads to accumulation of damage, causing cancer cell death. It targets tumor cells selectively, making it an effective treatment option for cancers with BRCA gene mutations.
It should be taken orally as prescribed by an oncologist, usually twice daily. It can be taken with or without food. Patients should follow the exact dosing schedule and avoid missing doses. Regular monitoring is important to ensure safe and effective treatment during therapy.
It is effective but requires careful monitoring due to potential side effects. Common effects are manageable, but serious risks like low blood cell counts may occur. It should only be used under medical supervision with regular blood tests to ensure safety and proper response to treatment.
Common side effects include nausea, fatigue, anemia, vomiting, and decreased appetite. These are usually manageable. Rare but serious side effects include bone marrow suppression and lung inflammation. Patients should seek medical attention if symptoms become severe or persist during treatment.

Reviews
There are no reviews yet.